Wei et al. (Wei et al., 2024) discovered that PAD, a key botanical drug in ‘yiqi jianpi jiedu huayu’, can combat HCC by targeting the PI3K/Akt pathway. This evidence concerns the gene AKT1 and hepatocellular carcinoma.